We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSNY:NASDAQPolestar Automotive Holding UK Limited Analysis

Data as of 2026-04-26 - not real-time

$17.92

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Polestar posted a record 60,119 vehicles sold in the latest quarter, translating to a 34% year‑over‑year increase and revenue that surged over 50% YoY, underscoring strong top‑line momentum. However, the company’s profitability remains deeply negative, with operating margins below -30% and a net loss that widened as cash burn accelerated. The balance sheet shows a debt load exceeding $6.6 billion against modest cash reserves, while free cash flow remains in the red. From a valuation standpoint, the stock trades at a price‑to‑sales multiple below 0.6, suggesting a discount relative to peers, but the lack of earnings and negative book value temper that appeal. Technically, the price sits just above the identified support of $16.6 and below the 20‑day SMA, with a bearish MACD histogram and an RSI hovering in the mid‑40s, indicating limited upside momentum. Overall, the market appears to be pricing in both the growth story and the substantial execution risks.
The sector’s inherent cyclicality and the EV industry’s regulatory exposure add layers of medium‑to‑high risk, amplified by a 30‑day volatility exceeding 60% and a beta near 1.0, implying that price swings will likely track broader market moves. Liquidity is adequate but not abundant, as average volumes are modest relative to the market cap. Given these dynamics, investors should weigh the compelling sales growth against the deep losses and balance‑sheet strain before committing capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with bearish MACD
  • High short‑term volatility
  • Recent earnings beat but widening losses

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained double‑digit sales growth
  • Discounted price‑to‑sales valuation
  • Potential operational improvements to narrow margins

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • EV market tailwinds offset by balance‑sheet risk
  • Uncertainty around profitability turnaround
  • Exposure to global regulatory and currency dynamics

Key Metrics & Analysis

Financial Health

Revenue Growth45.40%
Profit Margin-77.08%
P/E Ratio-2.2
ROA-14.66%
P/B Ratio-0.3
Op. Cash Flow$-914988992
Free Cash Flow$-943137856

Technical Analysis

TrendNeutral
RSI44.7
Support$16.59
Resistance$21.96
MA 20$19.22
MA 50$18.32
MA 200$23.12
MACDBearish
VolumeStable
Fear & Greed Index88.02

Valuation

Target Price$22.50
Upside/Downside25.56%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.94
Volatility61.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.